Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lamotrigine for Ketamine Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial

NCT02556060 is registered in ClinicalTrials.gov with Taipei City Hospital as lead sponsor.

NCT NCT02556060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02556060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lamotrigine for Ketamine Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial
Lead sponsor
Taipei City Hospital
Phase
Phase 2/3
Overall status
Completed
Start date
September 30, 2015
Completion date
May 1, 2017
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

addiction